Home Data Calendar Blog

NTLA

Tables

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Common Stock Value 0.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.000.000.000.000.000.000.00
Earnings Per Share Basic -1.46-1.38-1.40-1.17-1.38-1.49-1.33-1.96NANA-1.01NANANANANANANANANANANANANANANANANA
Earnings Per Share Diluted -1.46-1.38-1.40-1.17-1.38-1.49-1.33-1.96NANA-1.01NANANANANANANANANANANANANANANANANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Revenue From Contract With Customer Excluding Assessed Tax -1.9211.9913.5912.6113.5713.2714.0311.2512.857.206.556.456.5922.2216.2612.9210.9410.6211.1210.437.887.417.687.476.677.325.926.21
Revenue From Contract With Customer Including Assessed Tax 0.001.002.802.802.902.902.802.80-17.307.206.556.456.5922.2216.2612.9210.9410.6211.1210.437.887.417.687.476.677.325.926.21
Revenues -1.9211.9913.5912.6113.5713.2714.0311.2512.857.206.556.456.5922.2216.2612.9210.9410.6211.1210.437.887.417.687.476.677.325.926.21
Costs And Expenses 137.97143.10145.93124.56123.66118.80112.33155.5093.2779.2075.5752.8748.9950.3249.3045.9640.7135.9438.5834.2428.6331.5131.2729.9031.3823.1921.9319.16
Research And Development Expense 108.98113.70115.2897.12100.0396.6590.20133.0971.1660.4958.8839.2838.2339.7637.7734.6531.7327.5125.4623.7119.9223.2423.4722.4921.1717.4815.5613.43
General And Administrative Expense 28.9929.4030.6527.4523.6322.1422.1322.4022.1118.7116.6813.5910.7610.5711.5311.318.988.4313.1210.538.718.277.807.4110.215.716.375.73
Operating Income Loss -139.89-131.11-132.33-111.96-110.09-105.53-98.30-144.25-80.42-71.99-69.02-46.42-42.40-28.10-33.03-33.05-29.77-25.33-27.46-23.81-20.75-24.10-23.59-22.43-24.71-15.88-16.02-12.95
Allocated Share Based Compensation Expense 35.0435.3536.4027.2524.6325.2123.0718.4914.5615.4110.616.425.585.404.764.163.023.084.404.593.584.464.904.116.603.252.852.63
Profit Loss -132.16-122.22-123.68-103.13-113.41-113.23-100.68-146.87-81.24-71.64-68.81-46.20-42.19-27.84-32.39-31.81-28.28-23.63-25.68-21.94-19.07-22.70-22.22-21.36-23.96-15.36NANA
Net Income Loss -132.16-122.22-123.68-103.13-113.41-113.23-100.68-146.87-81.24-71.64-68.81-46.20-42.19-27.84-32.39-31.81-28.28-23.63-25.68-21.94-19.07-22.70-22.22-21.36-23.96-15.36-15.59-12.63
Comprehensive Income Net Of Tax -130.85-121.93-124.87-98.34-111.50-113.04-102.17-152.30-83.69-71.81-68.81-46.22-42.22-27.96-32.61-31.69-28.35-23.55-25.49-21.85-19.09-22.70-22.22-21.36NANANANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Assets 1300.981243.351323.241417.891520.111084.461110.421202.791294.461334.96672.24716.89676.32458.56490.83314.75334.28346.63352.44344.36347.31321.23339.78359.55376.24249.17264.98279.26
Liabilities 250.81205.94NANA284.53NANANANANANANANANANANANANANANANANANANANANANANA
Liabilities And Stockholders Equity 1300.981243.351323.241417.891520.111084.461110.421202.791294.461334.96672.24716.89676.32458.56490.83314.75334.28346.63352.44344.36347.31321.23339.78359.55376.24249.17264.98279.26
Stockholders Equity 1050.171037.411104.891190.841235.58824.95880.55953.751040.241107.10494.81545.87527.07329.62351.59247.76269.88275.65276.87264.34277.92263.27279.34295.50300.60175.85187.59199.88

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Assets Current 998.33893.49939.62963.671216.80858.95895.43875.37769.30814.77549.40601.08616.52416.25446.37269.76289.48295.94307.14303.69324.98298.83317.63337.72354.83229.05245.92261.08
Cash And Cash Equivalents At Carrying Value 226.75168.03171.81294.15523.51141.19147.78133.38123.41334.74129.88141.54160.02179.75361.6980.9957.2338.4449.1447.1058.86293.25305.54327.78340.68222.26241.05257.55
Marketable Securities Current 685.48686.76736.27639.39669.12687.00726.49721.87625.28463.53399.14442.52437.35228.2075.12169.27222.50247.48221.96NA255.20NANANANANANANA
Accounts Receivable Net Current 36.466.495.064.913.774.022.851.802.032.491.990.952.131.223.8613.374.623.604.193.597.552.818.617.4710.474.492.762.44
Prepaid Expense And Other Assets Current 49.6532.2126.4825.2220.4126.7318.3018.3218.5814.0218.3916.0717.027.095.706.135.136.414.713.523.372.773.482.483.682.302.111.08
Available For Sale Securities Debt Securities 785.34824.51900.28864.43738.45707.53759.10861.36962.64813.98421.40459.26437.35228.2075.12169.27227.25257.35226.70249.49255.20NANANANANANANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Property Plant And Equipment Gross 72.62NANANA61.12NANANA47.08NANANA35.27NANANA31.86NANANA25.67NANANA19.60NANANA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 39.86NANANA33.20NANANA26.11NANANA19.33NANANA13.87NANANA8.61NANANA4.33NANANA
Property Plant And Equipment Net 32.7633.8033.1931.6127.9226.6025.8723.7020.9719.9518.5316.1615.9415.6116.4017.2518.0017.2116.6916.6717.0616.9316.5816.0115.2713.5612.5811.42
Available For Sale Debt Securities Amortized Cost Basis 785.47826.63902.54865.20742.22714.73767.28868.61964.77814.15421.41459.27437.35228.1774.96168.89226.99257.01226.44249.43255.23NANANANANANANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Liabilities Current 115.2191.9599.85103.38126.55131.13123.76126.11125.8397.5773.9660.7064.2555.8759.1435.3035.6337.5238.4639.2340.5725.9125.1725.5831.3625.7926.3724.91
Accounts Payable Current 7.453.5511.636.895.154.387.5110.149.657.476.858.6910.467.780.013.873.944.551.853.692.711.750.341.922.172.192.271.43
Other Accrued Liabilities Current 4.0411.085.415.704.967.134.766.672.872.374.602.131.752.290.651.071.190.770.770.730.61NANANA0.68NANANA
Accrued Liabilities Current 67.0257.9849.5344.8260.8858.3844.8742.8843.3124.6337.1521.2125.5519.3515.3713.1013.2711.6411.907.7410.749.899.166.618.005.945.313.56
Contract With Customer Liability Current 22.1413.3521.9335.3443.8454.8261.8163.7663.7656.7622.5422.5422.5422.5437.9312.6412.6715.8219.6523.4327.1214.27NANA21.19NANANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Operating Lease Liability Noncurrent 96.75101.26105.58109.80114.0284.1060.0062.4864.9167.2763.2664.4933.6116.0017.3518.6712.63NANANANANANANANANANANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Stockholders Equity 1050.171037.411104.891190.841235.58824.95880.55953.751040.241107.10494.81545.87527.07329.62351.59247.76269.88275.65276.87264.34277.92263.27279.34295.50300.60175.85187.59199.88
Common Stock Value 0.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.000.000.000.000.000.000.00
Additional Paid In Capital Common Stock 2710.802567.202512.742473.822420.221898.091840.641811.681745.871729.031044.941027.19962.17722.50716.50580.07570.49547.91525.57487.56478.97445.23438.59432.53421.71272.99269.38266.08
Retained Earnings Accumulated Deficit -1658.38-1526.22-1403.99-1280.31-1177.19-1063.78-950.55-849.87-703.00-621.76-550.12-481.31-435.11-392.92-365.08-332.68-300.88-272.60-248.97-223.28-201.03-181.96-159.26-137.04-121.11-97.15-81.79-66.20
Accumulated Other Comprehensive Income Loss Net Of Tax -2.26-3.57-3.87-2.68-7.46-9.37-9.55-8.06-2.63-0.17-0.01-0.010.000.030.150.370.260.340.260.06-0.03NANANANANANANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Net Cash Provided By Used In Operating Activities -93.05-101.38-90.32-109.33-89.87-78.53-85.09-79.80-54.65-65.02-52.98-52.38-40.23-28.5657.42-38.55-28.66-25.45-27.68-21.45-8.54-12.45-22.50-17.77-21.31-16.89NANA
Net Cash Provided By Used In Investing Activities 45.9479.50-34.54-122.25-30.1547.6495.3447.47-159.12-399.3833.26-25.54-210.92-153.9892.9657.4527.88-31.6523.255.70-256.02-2.02-0.90-1.85-2.40-2.26NANA
Net Cash Provided By Used In Financing Activities 106.4819.102.522.22505.7623.985.8947.322.28668.687.1358.59234.090.60132.224.8619.5646.406.474.0030.162.181.166.72142.120.37NANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Net Cash Provided By Used In Operating Activities -93.05-101.38-90.32-109.33-89.87-78.53-85.09-79.80-54.65-65.02-52.98-52.38-40.23-28.5657.42-38.55-28.66-25.45-27.68-21.45-8.54-12.45-22.50-17.77-21.31-16.89NANA
Net Income Loss -132.16-122.22-123.68-103.13-113.41-113.23-100.68-146.87-81.24-71.64-68.81-46.20-42.19-27.84-32.39-31.81-28.28-23.63-25.68-21.94-19.07-22.70-22.22-21.36-23.96-15.36-15.59-12.63
Profit Loss -132.16-122.22-123.68-103.13-113.41-113.23-100.68-146.87-81.24-71.64-68.81-46.20-42.19-27.84-32.39-31.81-28.28-23.63-25.68-21.94-19.07-22.70-22.22-21.36-23.96-15.36NANA
Depreciation Depletion And Amortization 2.472.292.172.052.031.951.841.751.881.791.631.591.601.601.571.541.581.381.321.301.231.151.071.010.830.790.710.66
Increase Decrease In Accounts Receivable 29.961.430.151.14-0.261.171.05-0.23-0.460.501.04-1.180.91-2.65-9.508.751.02-0.590.60-3.964.73-5.801.14-3.005.981.730.32-4.01
Increase Decrease In Accounts Payable 3.94-7.715.121.170.75-1.62-3.65-0.062.400.74-1.69-0.921.617.34-3.53-0.37-0.032.20-1.651.360.301.53-1.660.06-0.260.440.28-0.95
Share Based Compensation 35.0435.3536.4027.2524.6325.2123.0718.4914.5615.4110.616.425.585.404.764.163.023.084.404.593.584.464.904.116.603.252.852.63

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Net Cash Provided By Used In Investing Activities 45.9479.50-34.54-122.25-30.1547.6495.3447.47-159.12-399.3833.26-25.54-210.92-153.9892.9657.4527.88-31.6523.255.70-256.02-2.02-0.90-1.85-2.40-2.26NANA
Payments To Acquire Property Plant And Equipment 1.524.334.303.833.914.243.981.432.874.542.942.411.010.701.040.842.571.750.941.531.592.020.901.852.402.261.274.16

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Net Cash Provided By Used In Financing Activities 106.4819.102.522.22505.7623.985.8947.322.28668.687.1358.59234.090.60132.224.8619.5646.406.474.0030.162.181.166.72142.120.37NANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Revenues -1.9211.9913.5912.6113.5713.2714.0311.2512.857.206.556.456.5922.2216.2612.9210.9410.6211.1210.437.887.417.687.476.677.325.926.21
Avencell 0.001.905.705.605.705.705.705.605.780.12NANANANANANANANANANANANANANANANANANA
Sparing Vision 0.500.400.500.40NANANANANANANANANANANANANANANANANANANANANANANANA
Onk Therapeutics, Research Materials Shippmet Services 0.000.200.000.10NANANANANANANANANANANANANANANANANANANANANANANANA
Regeneron Pharmaceuticals Inc, Hemophilia Co Co Agreements 3.101.802.802.903.503.202.201.500.601.101.00NANANANANANANANANANANANANANANANANA
Regeneron Pharmaceuticals Inc, Regeneron Arrangement -2.509.307.306.805.506.506.305.907.106.705.506.406.5022.2016.307.906.805.806.305.704.705.005.305.104.204.903.60NA
Revenue From Contract With Customer Excluding Assessed Tax -1.9211.9913.5912.6113.5713.2714.0311.2512.857.206.556.456.5922.2216.2612.9210.9410.6211.1210.437.887.417.687.476.677.325.926.21
Avencell 0.001.905.705.605.705.705.705.605.780.12NANANANANANANANANANANANANANANANANANA
Sparing Vision 0.500.400.500.40NANANANANANANANANANANANANANANANANANANANANANANANA
Onk Therapeutics, Research Materials Shippmet Services 0.000.200.000.10NANANANANANANANANANANANANANANANANANANANANANANANA
Regeneron Pharmaceuticals Inc, Hemophilia Co Co Agreements 3.101.802.802.903.503.202.201.500.601.101.00NANANANANANANANANANANANANANANANANA
Regeneron Pharmaceuticals Inc, Regeneron Arrangement -2.509.307.306.805.506.506.305.907.106.705.506.406.5022.2016.307.906.805.806.305.704.705.005.305.104.204.903.60NA
Revenue From Contract With Customer Including Assessed Tax 0.001.002.802.802.902.902.802.80-17.307.206.556.456.5922.2216.2612.9210.9410.6211.1210.437.887.417.687.476.677.325.926.21
Avencell 0.001.905.705.605.705.705.705.605.780.12NANANANANANANANANANANANANANANANANANA
Kyverna Therapeutics Inc 0.300.100.010.402.302.302.00NANANANANANANANANANANANANANANANANANANANANA

Plots across concepts


IncomeStatement
Operating Income Loss
Expenses
Other Nonoperating Income Expense
Balance Sheet
Liabilities Current
Assets
Property Plant And Equipment Net
Current Assets
Accounts Receivable Net Current
NonCurrent Assets
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
Property Plant And Equipment Net
Liabilities
Liabilities Current
Current Liabilities
Other Accrued Liabilities Current
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Payments To Acquire Businesses Net Of Cash Acquired
OperatingLeaseLiability
Operating Lease Liability Current
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Due Year Four

Line plots across dimensions of each concept